Stanford molecule turns cancer driver into self-destruct switch — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Stanford researchers designed a molecule that hijacks a major lymphoma-promoting protein, converting it from a cancer driver into a trigger that activates cancer cells' self-destruct machinery rather than merely blocking tumor growth.
- In mouse tests, the treatment completely eliminated aggressive human lymphoma tumors within 11 days, though researchers note substantially more testing is required.
Why it matters: If validated beyond mice, this approach could open a new class of cancer therapy that weaponizes oncogenic proteins against tumors instead of just suppressing them, potentially shrinking the timeline from lab to lymphoma treatment.
Ask SkimNews
